An urgent demand for natural compound alternatives to conventional medications has arisen due to global health challenges, such as drug resistance and the adverse effects associated with synthetic drugs. Plant extracts are considered an alternative due to their favorable safety profiles and potential for reducing side effects. Sweet basil (Ocimum basilicum L.) is a valuable plant resource and a potential candidate for the development of pharmaceutical medications. A single pure compound or a combination of compounds exhibits exceptional medicinal properties, including antiviral activity against both DNA and RNA viruses, antibacterial effects against both Gram-positive and Gram-negative bacteria, antifungal properties, antioxidant activity, antidiabetic potential, neuroprotective qualities, and anticancer properties. The plant contains various phytochemical constituents, which mostly consist of linalool, eucalyptol, estragole, and eugenol. For centuries, community and traditional healers across the globe have employed O. basilicum L. to treat a wide range of ailments, including flu, fever, colds, as well as issues pertaining to digestion, reproduction, and respiration. In addition, the current research presented underscores the significant potential of O. basilicum-related nanotechnology applications in addressing diverse challenges and advancing numerous fields. This promising avenue of exploration holds great potential for future scientific and technological advancements, promising improved utilization of medicinal products derived from O. basilicum L.

The productivity of vegetable crops is constrained by insect pests. The search for alternative insect pest control is becoming increasingly important and is including the use of plant-derived pesticides. Plant-derived pesticides are reported as effective in controlling various insect pests through natural mechanisms, with biodegradable organic materials, diverse bioactivity, and low toxicity to non-target organisms. An antifeedant approach for insect control in crop management has been comprehensively studied by many researchers, though it has only been restricted to plant-based compounds and to the laboratory level at least. Nano-delivery formulations of biopesticides offer a wide variety of benefits, including increased effectiveness and efficiency (well-dispersion, wettability, and target delivery) with the improved properties of the antifeedant. This review paper evaluates the role of the nano-delivery system in antifeedant obtained from various plant extracts. The evaluation includes the research progress of antifeedant-based nano-delivery systems and the bioactivity performances of different types of nano-carrier formulations against various insect pests. An antifeedant nano-delivery system can increase their bioactivities, such as increasing sublethal bioactivity or reducing toxicity levels in both crude extracts/essential oils (EOs) and pure compounds. However, the plant-based antifeedant requires nanotechnological development to improve the nano-delivery systems regarding properties related to the bioactive functionality and the target site of insect pests. It is highlighted that the formulation of plant extracts creates a forthcoming insight for a field-scale application of this nano-delivery antifeedant due to the possible economic production process.

Along with the increasing resistance of Candida spp. to some antibiotics, it is necessary to find new antifungal drugs, one of which is from the medicinal plant Red Betel (Piper crocatum). The purpose of this research is to isolate antifungal constituents from P. crocatum and evaluate their activities as ergosterol biosynthesis inhibitors via an in silico study of ADMET and drug-likeness analysis. Two new active compounds 1 and 2 and a known compound 3 were isolated, and their structures were determined using spectroscopic methods, while their bioactivities were evaluated via in vitro and in silico studies, respectively. Antifungal compound 3 was the most active compared to 1 and 2 with zone inhibition values of 14.5, 11.9, and 13.0 mm, respectively, at a concentration of 10% w/v, together with MIC/MFC at 0.31/1.2% w/v. Further in silico study demonstrated that compound 3 had a stronger ΔG than the positive control and compounds 1 and 2 with −11.14, −12.78, −12.00, and −6.89 Kcal/mol against ERG1, ERG2, ERG11, and ERG24, respectively, and also that 3 had the best Ki with 6.8 × 10⁻³, 4 × 10⁻⁴, 1.6 × 10⁻³, and 8.88 μM. On the other hand, an ADMET analysis of 1–3 met five parameters, while 1 had one violation of Ro5. Based on the research data, the promising antifungal constituents of P. crocatum allow P. crocatum to be proposed as a new antifungal candidate to treat and cure infections due to C. albicans.